Back to Search

Biomarkers in periodontal disease

AUTHOR Dhinsa, Gurpreet; Singh, Akanksha; Gupta, Sanjay
PUBLISHER LAP Lambert Academic Publishing (02/20/2023)
PRODUCT TYPE Paperback (Paperback)

Description
A biomarker or biological marker is a substance that is objectively measured and evaluated as an indicator of normal biologic process, pathogenic process or pharmacologic responses to a therapeutic intervention. An ideal diagnostic marker should indicate the presence of a disease process before extensive clinical damage has occurred. In the field of periodontology, traditional clinical criteria are often insufficient for determining sites of active disease, for monitoring the response to therapy or for measuring the degree of susceptibility to future disease progression. Biomarkers contribute knowledge about clinical pharmacology and provide a basis for the designing of clinical trials that expeditiously and definitively evaluate safety and efficacy.Researchers in the biotechnology and medical realm are currently investigating the use of oral fluids for the diagnosis of oral and systemic diseases and for drug development. The development of a wide spectrum of marker factors will be a primary goal of periodontal research.
Show More
Product Format
Product Details
ISBN-13: 9786206144397
ISBN-10: 6206144399
Binding: Paperback or Softback (Trade Paperback (Us))
Content Language: English
More Product Details
Page Count: 132
Carton Quantity: 54
Product Dimensions: 6.00 x 0.31 x 9.00 inches
Weight: 0.45 pound(s)
Country of Origin: US
Subject Information
BISAC Categories
Medical | Dentistry - General
Descriptions, Reviews, Etc.
publisher marketing
A biomarker or biological marker is a substance that is objectively measured and evaluated as an indicator of normal biologic process, pathogenic process or pharmacologic responses to a therapeutic intervention. An ideal diagnostic marker should indicate the presence of a disease process before extensive clinical damage has occurred. In the field of periodontology, traditional clinical criteria are often insufficient for determining sites of active disease, for monitoring the response to therapy or for measuring the degree of susceptibility to future disease progression. Biomarkers contribute knowledge about clinical pharmacology and provide a basis for the designing of clinical trials that expeditiously and definitively evaluate safety and efficacy.Researchers in the biotechnology and medical realm are currently investigating the use of oral fluids for the diagnosis of oral and systemic diseases and for drug development. The development of a wide spectrum of marker factors will be a primary goal of periodontal research.
Show More
Your Price  $87.88
Paperback